Aerobic vaginitis: antibiotic resistance trend and future actions of antimicrobial diagnostic stewardship.

The study objective is to examine epidemiological and microbiological aspects of aerobic vaginitis in female patients admitted to University Hospital of Campania "L. Vanvitelli" over five years. The most represented strains were E. coli (n = 153), Citrobacter spp. increasing from 2020, E. faecalis (n = 149), S. haemolitycus (n = 61), and Candida albicans (n = 87). The susceptibility patterns of a selection of gram-negative and gram-positive representative bacterial isolates were examined. Carbapenems, aminoglycosides, and fosfomycin were most effective against gram-negative bacteria, whereas vancomycin, daptomycin, and linezolid exhibited greater efficacy against gram-positive bacteria. None of the E. coli and Citrobacter spp. isolates produced extended-spectrum beta-lactamases, and the S. haemolyticus strains were methicillin-resistant. In gram-positive isolates, gentamicin susceptibility increased in 2020 and 2021 compared to clindamycin; erythromycin showed high resistance rates in 2020. Our findings indicate that integrating proper microbiological cultures into clinical practice could improve the management of aerobic vaginitis. Moreover, they highlight the necessity of establishing a nationwide surveillance guideline to mitigate antimicrobial resistance. Improvement actions in antimicrobial diagnostic stewardship must be considered when seeking the appropriate diagnosis and treatment for aerobic vaginitis.

The potential role of finerenone in patients with type 1 diabetes and chronic kidney disease.

Chronic kidney disease (CKD) represents a global health concern, associated with an increased risk of cardiovascular morbidity and mortality and decreased quality of life. Many patients with type 1 diabetes (T1D) will develop CKD over their lifetime. Uncontrolled glucose levels, which occur in patients with T1D as well as type 2 diabetes (T2D), are associated with substantial mortality and cardiovascular disease burden. T2D and T1D share common pathological features of CKD, which is thought to be driven by haemodynamic dysfunction, metabolic disturbances, and subsequently an influx of inflammatory and profibrotic mediators, both of which are major interrelated contributors to CKD progression. The mineralocorticoid receptor is also involved, and, under conditions of oxidative stress, salt loading and hyperglycaemia, it switches from homeostatic regulator to pathophysiological mediator by promoting oxidative stress, inflammation and fibrosis. Progressive glomerular and tubular injury leads to macroalbuminuria a progressive reduction in the glomerular filtration rate and eventually end-stage renal disease. Finerenone, a non-steroidal, selective mineralocorticoid receptor antagonist, is approved for treatment of patients with CKD associated with T2D; however, the benefit of finerenone in patients with T1D has yet to be determined. This narrative review will discuss treatment of CKD in T1D and the potential future role of finerenone in this setting.

Reduced levels of hepcidin associated with lower ferritin concentration and increased number of previous donations in periodic blood donors: A pilot study.

BACKGROUND: Hepcidin is one of the major negative regulators of iron balance. Periodic blood donors are highly susceptible to iron deficiency. Our goal was to evaluate the possible association between serum hepcidin levels and iron homeostasis parameters in periodic blood donors. MATERIALS AND METHODS: We enrolled a total of n = 39 periodic healthy blood donors (n = 24 M and n = 15 F). A solid phase enzyme-linked immunosorbent assay (ELISA) was performed to measure endogenous hepcidin-25 levels in serum biospecimens collected from each study participant. Statistical analysis evaluated possible associations between hepcidin levels and ferritin, transferrin, total iron binding capacity (TIBC), unsaturated iron binding capacity (UIBC), transferrin saturation (TSAT), and number of previous donations. RESULTS: Reduced serum hepcidin levels significantly correlated with lower ferritin concentration (r = 0.56, IC 95%: 0.51-0.60, p < 0.01). A multiple linear regression analysis showed that hepcidin levels were independently and negatively correlated with ferritin (p < 0.01). In addition, the number of previous blood donations was significantly associated with reduced hepcidin levels, independently of the other covariates (p < 0.01). CONCLUSION: Reduced serum hepcidin levels were significantly associated with reduced levels of ferritin and with increased number of previous donations suggesting its possible clinical role as non-invasive "point-of-care" in predicting iron deficiency among periodic blood donors.

An Attack on Zawadzki's Quantum Authentication Scheme.

Identification schemes are interactive cryptographic protocols typically involving two parties, a prover, who wants to provide evidence of their identity and a verifier, who checks the provided evidence and decides whether or not it comes from the intended prover. Given the growing interest in quantum computation, it is indeed desirable to have explicit designs for achieving user identification through quantum resources. In this paper, we comment on a recent proposal for quantum identity authentication from Zawadzki. We discuss the applicability of the theoretical impossibility results from Lo, Colbeck and Buhrman et al. and formally prove that the protocol must necessarily be insecure. Moreover, to better illustrate our insecurity claim, we present an attack on Zawadzki's protocol and show that by using a simple strategy an adversary may indeed obtain relevant information on the shared identification secret. Specifically, through the use of the principal of conclusive exclusion on quantum measurements, our attack geometrically reduces the key space resulting in the claimed logarithmic security being reduced effectively by a factor of two after only three verification attempts.

Epigenetic-based therapy in allogenic hematopoietic stem cell transplantation: Novel opportunities for personalized treatment.

Current management of patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT) lacks immunosuppressant drugs able to block the host immune response toward the graft antigens. Novel treatments may include epigenetic compounds (epidrugs) some of which have been yet approved by the Food and Drugs Administration for the treatment of specific blood malignancies. The most investigated in clinical trials for allo-HSCT are DNA demethylating agents (DNMTi), such as azacitidine (Vidaza) and decitabine (Dacogen) as well as histone deacetylases inhibitors (HDACi), such as vorinostat (Zolinza) and panobinostat (Farydak). Indeed, azacitidine monotherapy before allo-HSCT may reduce the conventional chemotherapy-related complications, whereas it may reduce relapse risk and death after allo-HSCT. Besides, a decitabine-containing conditioning regimen could protect against graft versus host disease (GVHD) and respiratory infections after allo-HSCT. Regarding HDACi, the addition of vorinostat and panobinostat to the conditioning regimen after allo-HSCT seems to reduce the incidence of acute GVHD. Furthermore, panobinostat alone or in combination with low-dose decitabine may reduce the relapse rate in high-risk patients with acute myeloid leukemia patients after allo-HSCT. We discuss the phase 1 and 2 clinical trials evaluating the possible beneficial effects of repurposing specific epidrugs which may guide personalized therapy in the setting of allo-HSCT.

Clinical epigenetics and acute/chronic rejection in solid organ transplantation: An update.

The lack of a precise stratification algorithm for predicting patients at high risk of graft rejection challenges the current solid organ transplantation (SOT) clinical setting. In fact, the established biomarkers for transplantation outcomes are unable to accurately predict the onset time and severity of graft rejection (acute or chronic) as well as the individual response to immunosuppressive drugs. Thus, identifying novel molecular pathways underlying early immunological responses which can damage transplant integrity is needed to reach precision medicine and personalized therapy of SOT. Direct epigenetic-sensitive mechanisms, mainly DNA methylation and histone modifications, may play a relevant role for immune activation and long-term effects (e.g., activation of fibrotic processes) which may be translated in new non-invasive biomarkers and drug targets. In particular, the measure of DNA methylation by using the blood-based "epigenetic clock" system may be an added value to the donor eligibility criteria providing an estimation of the heart biological age as well as a predictive biomarkers. Besides, monitoring of DNA methylation changes may aid to predict acute vs chronic graft damage in kidney transplantation (KT) patients. For example, hypermethylation of genes belonging to the Notch and Wnt pathways showed a higher predictive value for chronic injury occurring at 12 months post-KT with respect to established clinical parameters. Detecting higher circulating cell-free DNA (cfDNA) fragments carrying hepatocyte-specific unmethylated loci in the inter-alpha-trypsin inhibitor heavy chain 4 (ITIH4), insulin like growth factor 2 receptor (IGF2R), and vitronectin (VTN) genes may be useful to predict acute graft injury after liver transplantation (LT) in serum samples. Furthermore, hypomethylation in the forkhead box P3 (FOXP3) gene may serve as a marker of infiltrating natural Treg percentage in the graft providing the ability to predict acute rejection events after heart transplantation (HTx). We aim to update on the possible clinical relevance of DNA methylation changes regulating immune-related pathways underlying acute or chronic graft rejection in KT, LT, and HTx which might be useful to prevent, monitor, and treat solid organ rejection at personalized level.

Epigenetic-sensitive challenges of cardiohepatic interactions: clinical and therapeutic implications in heart failure patients.

Heart failure and liver dysfunction can coexist owing to complex cardiohepatic interactions including the development of hypoxic hepatitis and congestive hepatopathy in patients with heart failure as well as 'cirrhotic cardiomyopathy' in advanced liver disease and following liver transplantation. The involvement of liver dysfunction in patients with heart failure reflects crucial systemic hemodynamic modifications occurring during the evolution of this syndrome. The arterial hypoperfusion and downstream hypoxia can lead to hypoxic hepatitis in acute heart failure patients whereas passive congestion is correlated with congestive hepatopathy occurring in patients with chronic heart failure. Nowadays, liquid biopsy strategies measuring liver function are well established in evaluating the prognosis of patients with heart failure. Large randomized clinical trials confirmed that gamma-glutamyltransferase, bilirubin, lactate deihydrogenase, and transaminases are useful prognostic biomarkers in patients with heart failure after transplantation. Deeper knowledge about the pathogenic mechanisms underlying cardiohepatic interactions would be useful to improve diagnosis, prognosis, and treatments of these comorbid patients. Epigenetic-sensitive modifications are heritable changes to gene expression without involving DNA sequence, comprising DNA methylation, histone modifications, and noncoding RNAs which seem to be relevant in the pathogenesis of heart failure and liver diseases when considered in a separate way. The goal of our review is to highlight the pertinence of detecting epigenetic modifications during the complex cardiohepatic interactions in clinical setting. Moreover, we propose a clinical research program which may be useful to identify epigenetic-sensitive biomarkers of cardiohepatic interactions and advance personalized therapy in these comorbid patients.

Blood transfusions and adverse acute events: a retrospective study from 214 transfusion-dependent pediatric patients comparing transfused blood components by apheresis or by whole blood.

INTRODUCTION: Blood transfusion is a lifesaving procedure for patients affected by hematological diseases or hemorrhage risk. AIM: This retrospective study was aimed to evaluate clinical safety of pediatric transfusions by comparing the frequency of adverse events caused by apheretic blood components vs whole blood. METHODS: From 2011 to 2015, 214 patients (blood malignancy patients, n = 144 and thalassemic patients, n = 70) received 12 531 units of blood components. The adverse acute reactions occurred during patient hospitalization were reported to the Hemovigilance system and assessed by fitting a logistic mixed-effect model. RESULTS: A total of 33 (0.3%) adverse acute events occurred. Odds ratio (OR) of adverse events from apheresis vs whole blood transfusion adjusted by patient classification was not statistically significant (OR [95% CI], 0.75 [0.23-2.47]). CONCLUSION: Our findings showed no significant differences in the prevalence of adverse acute events between blood component collected by apheresis vs whole blood in our study center.

Pathogenic mechanisms and current epidemiological status of HEV infection in asymptomatic blood donors and patients with chronic diseases.

In recent years, the seroprevalence of anti-hepatitis E virus immunoglobulins (HEV) has increased in European countries with significant variability among the different geographical areas. HEV infection is spread in a wide range of animal species of which domestic pigs and wild boar represent the main reservoirs of genotype 3 and 4 (the genotypes present also in Europe). European citizens are incidental hosts, mainly infected by direct contact or consumption of foods derived from undercooked or insufficient hygiene handling infected pork products or wild boar meat. Epidemiologically, the HEV incidence is low in humans but serological data show a high proportion of subclinical infection caused by genotypes 3 or 4. In the general population, asymptomatic infection represents a high potential risk in particular subjects such as blood component recipients or occupationally exposed workers. This review offers a landscape of the current epidemiological status of HEV infection (genotypes 1, 2, 3, 4, 7) both in European asymptomatic subjects, patients with chronic diseases, and domestic pig impact on humans. We also underline advantages/disadvantages of high sensitivity and specificity tests using for detecting viral RNA or anti-HEV antibodies.

Compromised nutritional status in patients with end-stage liver disease: Role of gut microbiota.

BACKGROUND: Patients with end-stage liver disease (ESLD) have a compromised nutritional status because of the liver crucial role in regulating metabolic homeostasis and energy balance. DATA SOURCES: A systematic review of literature based on extensive relevant articles published from 2001 to 2017 in English in PubMed database was performed by searching keywords such as liver disease, non-alcoholic liver disease, alcoholic liver disease, malnutrition, epigenetics, gut microbiota, and probiotics. RESULTS: Liver transplantation would be one eligible therapy for ESLD patients, even if, the clinical outcome is negatively influenced by malnutrition and/or infections. The malnutrition is a condition of nutrient imbalance with a high incidence in ESLD patients. An accurate evaluation of nutritional status could be fundamental for reducing complications and prolonging the survival of ESLD patients including those undergoing liver transplantation. In addition, the interaction among nutrients, diet and genes via epigenetics has emerged as a potential target to reduce the morbidity and mortality in ESLD patients. The malnutrition induces changes in gut microbiota causing dysbiosis with a probable translocation of bacteria and/or pathogen-derived factors from the intestine to the liver. Gut microbiota contribute to the progression of chronic liver diseases as well as hepatocellular carcinoma. The administration of probiotics modulating gut microbiota could improve all chronic liver diseases. CONCLUSIONS: This review provides an update on malnutrition status linked to epigenetics and the potential benefit of some probiotics on the management of ESLD patients. In support of this view and to reveal the constant and growing interest in this field, some clinical trials are reported.

Perfil epidemiológico de pacientes com HIV/AIDS do Estado do Paraná: estudo ecológico / Perfil epidemiológico del VIH/SIDA en el Estado de Paraná: estudio ecológico / Epidemiological profile of the HIV/AIDS in the State of Paraná: ecological study

Objetivo: descrever o perfil epidemiológico do HIV/AIDS nos municípios do estado do Paraná. Método: estudo ecológico que utilizou como unidade de análise os 399 municípios do Estado do Paraná nos quais são operacionalizados pelas ações do Programa Estadual de Controle da DST/AIDS e Hepatites Virais, analisando o perfil epidemiológico do Sistema Nacional de Vigilância em Saúde 2011. A coleta e análise dos dados ocorreu no mês de outubro de 2015. Resultados: até junho de 2010, foram registrados 28.376 casos. As cinco cidades com maior número de casos foram: Curitiba (10.549), Londrina (2.166), Foz do Iguaçu (1.348), Maringá (1.124) e Paranaguá (1.113). Em relação às gestantes portadoras do HIV/AIDS, foram notificados 3.951 casos e 786 casos por transmissão vertical. Conclusão: observa-se que o quadro epidemiológico de HIV/AIDS no Paraná apresenta crescimento do número de casos, com elevado índice na região portuária .

Objective: describe the epidemiological profile or make municipalities HIV/AIDS do Paraná state. Method: ecological study that used as a unit of 399 municipalities Analyze you of the State of Paraná What are we operationalized Actions by the State Control Program STD/AIDS and Hepatitis deviate, do analysis or national surveillance system epidemiological profile Health in 2011. The pigtail And Analysis two occurred no given month of October 2015. Results: as of June 2010, were recorded 28,376 cases. As a five-speed larger number with cases were: Curitiba (10,549), Londrina (2,166), Foz do Iguaçu (1,348), Maringá (1,124) and Paranaguá (1,113). Regarding how pregnant women carrying the HIV/AIDS virus do, they reported 3,951 cases and 786 cases per vertical transmission. Conclusion: Framework notes is that epidemiological or non-Parana HIV / AIDS number growth presents from COM cases in the High Port Region rate .

Objetivo: describir el perfil epidemiológico o hacer municipios VIH/SIDA do Parana. Método: estudio ecológico que utiliza como unidad de 399 municipios a analizar el estado de Paraná qué somos operacionalizamos acciones para el Control Estatal de ETS/SIDA y la hepatitis, desvío de realizar el análisis o la vigilancia epidemiológica Nacional de Salud del sistema en 2011. La cola de cerdo y dos análisis no se le dio el mes de octubre de 2015. Resultados: en junio de 2010, se han registrado 28,376 casos. Como cinco velocidades con mayor número de casos fueron: Curitiba (10,549), Londrina (2166), Foz de Iguazú (1348), Maringa (1124) y Paranaguá (1113). En la medida en qué las mujeres embarazadas con VIH/SIDA, se notificaron 3.951 casos y 786 casos de transmisión vertical. Conclusión: notas marco es que o el VIH / SIDA no Parana número Crecimiento epidemiológica presenta casos COM en la región de alta velocidad del puerto .

Screening tests for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus in blood donors: evaluation of two chemiluminescent immunoassay systems.

Automated chemiluminescent immunoassays (CLIAs) are useful for the detection of hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus 1/2 antigen/antibodies (HIV 1/2 Ag/Ab) in blood donor screening. Eight hundred and forty serum samples were tested for hepatitis B surface antigen (HBsAg), HCV antibodies (anti-HCV), and HIV1/2 Ag/Ab in parallel using 2 different CLIAs (Abbott Architect i2000SR and Roche Cobas e411). The concordance between the 2 systems was high (Cohen's kappa 0.97 for HBsAg, 0.77 for anti-HCV, 0.92 for HIV1/2 Ag/Ab) and the specificity and the positive predictive value were comparable. Among the 12 discrepant results, 11 were false-positive and 1 (reactive by Architect) was true-positive for anti-HCV. Positivity for HBV DNA, HCV RNA, and HIV RNA was recorded in 90.9%, 38.9%, and 100% of true-positive samples, respectively. This study represents the first stringent comparison between Architect i2000SR and Cobas e411 in blood donors. We observed a good correlation and high agreement among HBV, HCV, and HIV with the 2 automated systems.

Intravenous human immunoglobulin treatment of serum from HLA-sensitized patients in kidney transplantation.

OBJECTIVE: Intravenous immunoglobulin (IVIG) products are known to have beneficial immunomodulatory effects on several inflammatory and autoimmune disorders. These effects could be attributed to a different inhibitory action on complement factors, but other mechanisms could be implicated, e.g., immunocomplexes development and/or anti-idiotypic antibodies. Positive results on the reduction of anti-Human Leukocyte Antigens (HLA) antibodies in highly sensitized patients have also been found. The present study focuses on the effect of IVIG on the reduction of Panel Reactive Antibody level and crossmatch positivity in sensitized patients awaiting kidney transplantation. METHODS: The study was performed adapting an in vitro assay on sensitized patients' sera in waiting list for kidney transplantation. Sera of twelve highly sensitized patients were evaluated for the cytotoxicity inhibition after 10% IVIG treatment. RESULTS: A reduction of anti- HLA antibody levels was observed in 75% (9/12) of treated patients in vitro, while 25% (3/12) resulted unresponsiveness. Particularly, our data showed a significantly higher Panel Reactive Antibody reduction for T lymphocytes (p<0.010) than B lymphocytes (p<0.032). CONCLUSIONS: In this study, we have used an in vitro assay to investigate susceptibility to desensitization with IVIG treatment of sensitized patient sera. These findings reveal that the variable effect of IVIG on reducing Panel Reactive Antibody in our immunized patients could be attributed to a different inhibitory action on complement, likely due to the type and the titre of anti-HLA antibodies.

Efectividad de la estrategia para la prevención del dengue en un barrio del municipio de Floridablanca 2011-2012 / Effectiveness of the strategy for the prevention of dengue in a neighborhood of the municipality of Floridablanca 2011-2012

Introducción: El dengue representa un problema prioritario en salud pública en el país y en Santander. Como respuesta a esta problemática en el año 2006 se diseñó, se validó y se implementó la estrategia “lava tu pila y hazle imposible la vida al zancudo” enfocada hacia la adopción de comportamientos para la prevención y control del dengue, lo que permitió que en esta investigación se planteara como objetivo determinar la efectividad de las acciones desarrolladas a través de la estrategia para disminuir los casos de dengue en el barrio Lagos II del Municipio de Floridablanca durante los años 2011- 2012. Materiales y Métodos: Se realizó un estudio de intervención cuasi experimental. El tamaño de la muestra fue de 143 amas de casa y jefes de hogar en cada uno de los barrios. Resultados: En la población del barrio de intervención se encontró un comportamiento final orientado hacia las etapas de decisión, acción y mantenimiento. La población resalta la pila como el mayor criadero con un 62.8%. Existió una reducción del 78,1% en las pilas positivas. Al inicio del proceso se encontró un índice de 22,8 pasando a ser al final de 5.88. Se evitaran 25 casos de dengue, lo que determina un beneficio de $ 80.967.250 frente a un costo de $ 39.849.400. Desde lo cualitativo, los cambios de conducta alcanzados reconocen los cambios individuales y colectivos en la población intervenida. Discusión y Conclusiones: El 72.27% de la población intervenida adoptó el comportamiento promovido, ubicándose en la etapa de mantenimiento según el modelo Transteórico. La intervención realizada permitió la reducción del índice aédico y se reconoce que el beneficio económico al manejar estrategias de prevención de la enfermedad y promoción de la salud en lugar de brindar atención médica es del 50% menos de los gastos generados por atención clínica.

Introduction: The dengue represents a major public health problem in the country and in Santander. As a response to this problem in the year 2006 was designed, validated and implemented the strategy "wash your stack and make long-leg’s life hard” focus on the adoption of behaviors for the prevention and control of dengue, which allowed in this research to set as objective to determine the effectiveness of the actions developed through the strategy to reduce the cases of dengue in the Lakes district II of the Municipality of Floridablanca during the years 2011-2012. Materials and Methods: A quasi-experimental intervention study was carried out. The target population was 143 head of the family house wives in each neighborhood. Results: It was found in the target population a final behavior-oriented to the decision-making, action and maintenance stages. The population highlights the stack as the largest kennel with a 62.8 %. There was a positive reduction of 78.1 % positive in the stacks. At the beginning of the process, it was found an average of 22.8 compared to the 5.88 at the end. It was avoided 25 cases of dengue, which determines a profit of $80,967,250 compared to a cost of $39,849,400. From the qualitative point of view, the behavioral changes achieved are recognized not only individually but also and collectively in the population underwent. Discussion and Conclusions: The 72.27 % of the target population adopted the promoted behavior, ranking in the maintenance stage according to the trans-theoreticalc model. The carried out intervention led to the reduction of the aédico average and recognizes the economic benefit when managing strategies for the prevention of the disease and health promotion , instead of providing medical care. It is to say, 50% less than the costs generated by clinical care.